fda compounding glp-1 crackdown news today New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our 🚨 Important update on compounded

The increasingly nuanced molecular subtypes of breast cancer have enhanced the comprehension and precision treatment of this disease

Trulicity has been linked to dangerously low blood sugar levels, though this is rare

June 2026 Update: OROS has begun rolling out USP Residual Solvent Analysis on all newly manufactured batches, screening for trace residual solvents including Acetonitrile, Methanol, DMF, and Dichloromethane as part of our continued commitment to comprehensive batch-level quality control

The difference is that you are more likely to have unused solution in the 60 mg vial if you are on a low dose

In theory, 1 g of edetate calcium can theoretically bind 620 mg of lead, but in reality only about 5 mg per gram is actually excreted into the urine in lead poisoned patients

Server configurations need regular patching, security logs must be monitored, and mobile operating system updates can easily disrupt custom video modules